PMC:7455778 / 15719-16409 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T110","span":{"begin":17,"end":31},"obj":"Disease"},{"id":"T111","span":{"begin":49,"end":57},"obj":"Disease"},{"id":"T112","span":{"begin":228,"end":236},"obj":"Disease"},{"id":"T113","span":{"begin":276,"end":290},"obj":"Disease"},{"id":"T114","span":{"begin":474,"end":482},"obj":"Disease"},{"id":"T115","span":{"begin":544,"end":558},"obj":"Disease"},{"id":"T116","span":{"begin":600,"end":614},"obj":"Disease"},{"id":"T117","span":{"begin":648,"end":656},"obj":"Disease"}],"attributes":[{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0003799"},{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0003799"},{"id":"A114","pred":"mondo_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0003799"},{"id":"A116","pred":"mondo_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/MONDO_0003799"},{"id":"A117","pred":"mondo_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"The frequency of conjunctivitis in patients with COVID-19 has not been fully quantified to date, reporting very different data regarding its prevalence and incidence. A study analyzing a sample of 1099 patients hospitalized for COVID-19 disease in China found a prevalence of conjunctivitis symptoms of only 0.8% and other small series have reported a prevalence around 3% [4, 6, 7]. However, Wu P. et al. [8] found that as high as 31.6% (95% CI, 17.5–48.7) of hospitalized COVID-19 patients presented ocular signs and symptoms compatible with conjunctivitis. Our results show an 11.6% prevalence of conjunctivitis among hospitalized patients with COVID-19, differing from previous results."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T126","span":{"begin":58,"end":61},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T127","span":{"begin":167,"end":168},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T128","span":{"begin":185,"end":186},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T129","span":{"begin":260,"end":261},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T130","span":{"begin":350,"end":351},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T131","span":{"begin":370,"end":375},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":"The frequency of conjunctivitis in patients with COVID-19 has not been fully quantified to date, reporting very different data regarding its prevalence and incidence. A study analyzing a sample of 1099 patients hospitalized for COVID-19 disease in China found a prevalence of conjunctivitis symptoms of only 0.8% and other small series have reported a prevalence around 3% [4, 6, 7]. However, Wu P. et al. [8] found that as high as 31.6% (95% CI, 17.5–48.7) of hospitalized COVID-19 patients presented ocular signs and symptoms compatible with conjunctivitis. Our results show an 11.6% prevalence of conjunctivitis among hospitalized patients with COVID-19, differing from previous results."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T85","span":{"begin":17,"end":31},"obj":"Phenotype"},{"id":"T86","span":{"begin":276,"end":290},"obj":"Phenotype"},{"id":"T87","span":{"begin":544,"end":558},"obj":"Phenotype"},{"id":"T88","span":{"begin":600,"end":614},"obj":"Phenotype"}],"attributes":[{"id":"A85","pred":"hp_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/HP_0000509"},{"id":"A86","pred":"hp_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/HP_0000509"},{"id":"A87","pred":"hp_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/HP_0000509"},{"id":"A88","pred":"hp_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/HP_0000509"}],"text":"The frequency of conjunctivitis in patients with COVID-19 has not been fully quantified to date, reporting very different data regarding its prevalence and incidence. A study analyzing a sample of 1099 patients hospitalized for COVID-19 disease in China found a prevalence of conjunctivitis symptoms of only 0.8% and other small series have reported a prevalence around 3% [4, 6, 7]. However, Wu P. et al. [8] found that as high as 31.6% (95% CI, 17.5–48.7) of hospitalized COVID-19 patients presented ocular signs and symptoms compatible with conjunctivitis. Our results show an 11.6% prevalence of conjunctivitis among hospitalized patients with COVID-19, differing from previous results."}

{"project":"LitCovid-sentences","denotations":[{"id":"T163","span":{"begin":0,"end":166},"obj":"Sentence"},{"id":"T164","span":{"begin":167,"end":383},"obj":"Sentence"},{"id":"T165","span":{"begin":384,"end":559},"obj":"Sentence"},{"id":"T166","span":{"begin":560,"end":690},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The frequency of conjunctivitis in patients with COVID-19 has not been fully quantified to date, reporting very different data regarding its prevalence and incidence. A study analyzing a sample of 1099 patients hospitalized for COVID-19 disease in China found a prevalence of conjunctivitis symptoms of only 0.8% and other small series have reported a prevalence around 3% [4, 6, 7]. However, Wu P. et al. [8] found that as high as 31.6% (95% CI, 17.5–48.7) of hospitalized COVID-19 patients presented ocular signs and symptoms compatible with conjunctivitis. Our results show an 11.6% prevalence of conjunctivitis among hospitalized patients with COVID-19, differing from previous results."}

{"project":"LitCovid-PubTator","denotations":[{"id":"392","span":{"begin":35,"end":43},"obj":"Species"},{"id":"393","span":{"begin":202,"end":210},"obj":"Species"},{"id":"394","span":{"begin":483,"end":491},"obj":"Species"},{"id":"395","span":{"begin":634,"end":642},"obj":"Species"},{"id":"396","span":{"begin":17,"end":31},"obj":"Disease"},{"id":"397","span":{"begin":49,"end":57},"obj":"Disease"},{"id":"398","span":{"begin":228,"end":236},"obj":"Disease"},{"id":"399","span":{"begin":276,"end":299},"obj":"Disease"},{"id":"400","span":{"begin":474,"end":482},"obj":"Disease"},{"id":"401","span":{"begin":544,"end":558},"obj":"Disease"},{"id":"402","span":{"begin":600,"end":614},"obj":"Disease"},{"id":"403","span":{"begin":648,"end":656},"obj":"Disease"}],"attributes":[{"id":"A392","pred":"tao:has_database_id","subj":"392","obj":"Tax:9606"},{"id":"A393","pred":"tao:has_database_id","subj":"393","obj":"Tax:9606"},{"id":"A394","pred":"tao:has_database_id","subj":"394","obj":"Tax:9606"},{"id":"A395","pred":"tao:has_database_id","subj":"395","obj":"Tax:9606"},{"id":"A396","pred":"tao:has_database_id","subj":"396","obj":"MESH:D003231"},{"id":"A397","pred":"tao:has_database_id","subj":"397","obj":"MESH:C000657245"},{"id":"A398","pred":"tao:has_database_id","subj":"398","obj":"MESH:C000657245"},{"id":"A399","pred":"tao:has_database_id","subj":"399","obj":"MESH:D051271"},{"id":"A400","pred":"tao:has_database_id","subj":"400","obj":"MESH:C000657245"},{"id":"A401","pred":"tao:has_database_id","subj":"401","obj":"MESH:D003231"},{"id":"A402","pred":"tao:has_database_id","subj":"402","obj":"MESH:D003231"},{"id":"A403","pred":"tao:has_database_id","subj":"403","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The frequency of conjunctivitis in patients with COVID-19 has not been fully quantified to date, reporting very different data regarding its prevalence and incidence. A study analyzing a sample of 1099 patients hospitalized for COVID-19 disease in China found a prevalence of conjunctivitis symptoms of only 0.8% and other small series have reported a prevalence around 3% [4, 6, 7]. However, Wu P. et al. [8] found that as high as 31.6% (95% CI, 17.5–48.7) of hospitalized COVID-19 patients presented ocular signs and symptoms compatible with conjunctivitis. Our results show an 11.6% prevalence of conjunctivitis among hospitalized patients with COVID-19, differing from previous results."}